View highlights and coverage from leading international Respiratory congresses
We discuss with Prof. Michael Wechsler (National Jewish Health, Denver, CO, USA) the clinical evidence supporting the use of dupilumab in patients with asthma and specifically the major findings from the long-term safety evaluation of dupilumab in the LIBERTY ASTHMA TRAVERSE trial (NCT02134028). Questions 1. What are the major unmet needs in the biologic treatment […]
Richard van Zyl-Smit (University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa) kindly took the time to speak with us about maximising the benefit of inhaler therapy and recent development being made in this field. Questions What are the major unmet needs in the use of inhaled therapies for the control of […]
We were delighted to discuss with Vasileios Kouranos (Royal Brompton Hospital, London, UK) the current unmet need in the treatment of pulmonary and cardiac sarcoidosis alongside the therapeutic advances being made. Questions Could you give us a brief overview of pulmonary and cardiac sarcoidosis, their prevalence and prognosis? (0:22) What are the major unmet needs […]
During the ERS International Congress 2020, it was great to catch up with our Editorial Board member, Prof. Peter J Barnes (Imperial College, London, UK), to continue the discussion around Smart Inhalers and how they could help optimise inhaler use in patients. Questions How common is poor adherence and inhaler technique in people with asthma […]
Following his recent publication in the Lancet Respiratory Medicine, and presentation at the ERS Congress, we spoke with Prof. Liam Heaney (Queen’s University, Belfast, Northern Ireland, UK) about the composite biomarker approach to optimising steroid dosage in patients with severe asthma. Questions Why is there a need for new approaches to optimising steroid dosage in people […]
Following his presentation at the ERS Congress, Dr. Kai-Michael Beeh (Insaf Respiratory Research Institute, Wiesbaden, Germany) caught up with us to continue the discussion around green inhalers. Questions 1. Could you give us an overview of the environmental impact of asthma inhaler use? (0:22) 2. How do dry powder inhalers compare to metered-dose inhalers in […]
Editorial Board member, Prof. Antonio Spanevello (University of Insurbria, Varese, Italy), spoke with us about chronic cough and its management. Questions 1. When is cough defined as chronic in adults? (0:29) 2. May chronic cough be due to any identifiable causes? (1:12) 3. When is chronic cough defined as ‘chronic refractory cough’ or ‘chronic idiopathic […]
We were delighted to catch up with our Editorial Board member, Prof. Toby Maher (University of Southern California, Los Angeles, CA, USA) during the ERS Virtual Congress, to discuss the ISABELA study in IPF (NCT03711162) and the challenges the trial has faced during the COVID-19 pandemic. Questions What are the major unmet needs in the […]
We were delighted to speak with Prof. Christopher Butler (University of Oxford, Oxford, UK) about antiviral therapies for influenza and, in particular, the findings from the ALIC4E trial. Questions 1. What are the current recommendations for the use of antiviral therapy for the treatment of influenza? (0:07) 2. Why is oseltamivir not more widely used […]
Get the latest clinical insights from touchRESPIRATORY
